SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment.

Detailed Description

SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows for the detection, annotation, and pre‑classification of genomic variants from complex NGS data, facilitating decision‑making in oncology, rare diseases, and hereditary disorders.

SOPHiA DDM Platform

Principle of operation

SOPHiA DDM® is a web‑based platform powered by artificial intelligence designed for genomic data analysis, automatically performing quality control, alignment, and variant detection. It then executes a comprehensive variant annotation from multiple sources and pre‑classifies them into different pathogenicity categories. The platform facilitates interpretation through integrated databases and allows the generation of custom variant reports.

SOPHiA DDM principle of operation

Clinical applications

It is aimed at genomic analysis in oncology, rare diseases, and hereditary disorders. The platform is designed to facilitate rapid and confident decision‑making through the detection, annotation, and pre‑classification of genomic variants.

Benefits

In genomics, the platform helps overcome bottlenecks by:

Seamless integration of clinical genomics workflows, reducing operational barriers thanks to its web access, single workspace, and new interface. Prioritisation of variants, simplification of interpretation, and acceleration of reporting. AI and machine learning algorithms aimed at increasing positive findings and improving confidence in the analysis of complex variants.

Intended user / audience

Solution aimed at clinical genomics laboratories, healthcare institutions, and precision medicine teams that need to integrate genomic analysis workflows in areas such as oncology, rare diseases, and hereditary disorders, with the ability to work in IVD or RUO environments depending on the application and the corresponding mode of use.

Key Features

SaaS platform for clinical genomic analysis based on artificial intelligence Automatic detection, annotation and pre‑classification of genetic variants Integration with multiple databases for proper management of identified variants Generation of customised and clinically actionable reports Access to a global community of genomics experts High security and data encryption in compliance with international regulations Intuitive and easy‑to‑use interface with fast response time
×

Area:

Molecular Genetics, Software, Software solutions for germline analysis

Technology:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)

VarSome Clinical

VarSome Clinical is a CE‑IVDR platform for clinical interpretation of NGS data that turns genomic data into actionable information. The software performs calling, annotation, classification and prioritisation of germline and somatic variants, linking them with curated evidence to support faster and more reliable diagnostic decisions. Detailed Description Principle of operation VarSome Clinical is a comprehensive…
Varsome